NCT00330421 2014-04-30Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)National Cancer Institute (NCI)Phase 2 Completed15 enrolled 7 charts